Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NEU1 | Q99519 | 13/20 | 0.40 |
| ▸ | NEU2 | Q9Y3R4 | 12/20 | 0.40 |
| ▸ | NEU3 | Q9UQ49 | 8/20 | 0.40 |
| ▸ | NEU4 | Q8WWR8 | 7/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17297667 | 0.87 | NEU2 (0.49) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL29842099 | 0.87 | NEU2 (0.49) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL24418448 | 0.87 | NEU2 (0.49) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL19087135 | 0.87 | NEU2 (0.42) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL14669264 | 0.83 | L3MBTL1 (0.36) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL31225865 | 0.78 | CD22 (0.51) | — | |
| SCHEMBL14725954 | 0.77 | NANP (0.41) | NEU1NEU2NEU3NEU4 | |
| SCHEMBL29863241 | 0.77 | L3MBTL1 (0.39) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL17447095 | 0.77 | L3MBTL1 (0.41) | NEU1NEU2NEU3NEU4L3MBTL1 | |
| SCHEMBL19106880 | 0.77 | L3MBTL1 (0.41) | NEU1NEU2NEU3NEU4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022150726-A1 | HYPOIMMUNOGENIC BIOTHERAPEUTICS | OSPREY BIOPHARMACEUTICALS, INC. (US) | 2022-07-14 | — | — | WO | disclosed |